EG Bio Launches Edel X HA Filler

Strengthening EG Bio’s proprietary aesthetic product portfolio

In November 2023, EG Bio Co., Ltd. officially launched Edel X HA Filler, marking an important milestone in the expansion of the company’s proprietary aesthetic product lineup. The launch of Edel X reflects EG Bio’s strategic focus on developing and introducing its own brands alongside its global distribution activities. With Edel X, EG Bio expands its portfolio with a hyaluronic acid–based filler designed for professional aesthetic markets and international distribution.

About Edel X

Edel X is EG Bio’s proprietary hyaluronic acid (HA) filler developed for professional aesthetic applications. The product line is positioned to support facial aesthetic treatments, with an emphasis on consistency, stability, and suitability for global markets.

Edel X has been introduced as part of EG Bio’s long-term brand strategy, aligned with international regulatory pathways and distributor requirements. The product reflects EG Bio’s commitment to building globally positioned brands supported by structured market development.

Why the Edel X Launch Is Important

The launch of Edel X represents a significant step in EG Bio’s evolution, strengthening its role as both a global distributor and a brand owner. By introducing a proprietary HA filler, EG Bio enhances its ability to support distribution partners with differentiated products and long-term brand opportunities.

Edel X allows EG Bio to offer greater portfolio depth while maintaining a clear focus on professionalism, compliance, and sustainable international growth.